{"675551":{"#nid":"675551","#data":{"type":"event","title":"Georgia CTSA TL1\/TL32 Visiting Scientist Program","body":[{"value":"\u003Cp\u003E\u003Cbr\u003E\u003Ca href=\u0022https:\/\/ncats.nih.gov\/about\/our-staff\/ronzettimh\u0022\u003EMichael H. Ronzetti\u003C\/a\u003E\u003Cbr\u003E\u003Cstrong\u003EGraduate Student\u003C\/strong\u003E\u003Cbr\u003E\u003Cstrong\u003EEarly Translation Branch\u003C\/strong\u003E\u003Cbr\u003E\u003Cstrong\u003EDivision of Preclinical Innovation\u003C\/strong\u003E\u003Cbr\u003E\u003Cstrong\u003ENational Center for Advancing Translational Sciences\u003C\/strong\u003E\u003Cbr\u003E\u003Cstrong\u003ENational Institutes of Health\u003C\/strong\u003E\u003Cbr\u003E\u003Cbr\u003E\u003Ca href=\u0022https:\/\/zoom.us\/meeting\/register\/tJEude-qqTouHNDjsE39gD1TectAc9atAKfZ#\/registration\u0022 target=\u0022_blank\u0022\u003E\u003Cstrong\u003EREGISTER HERE\u003C\/strong\u003E\u003C\/a\u003E\u003Cstrong\u003E for Zoom link\u003C\/strong\u003E\u003Cbr\u003E\u003Cbr\u003ELyme disease remains a significant public health concern with over half a million cases reported annually that results in an economic burden of nearly $3 billion. Current treatments fail to completely clear the infection in nearly 15% of cases and lose effectiveness as the disease progresses, highlighting the need for new and more potent therapeutics. By employing parallel approaches\u2014phenotypic screening of live Borrelia burgdorferi sensu lato, the causative agent of Lyme disease, and target-based drug design focusing on a known protease\u2014we have identified several promising candidates with potential applications for eradicating the bacteria in vivo.\u003C\/p\u003E","summary":"","format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003E\u0022Advancing Lyme Disease Therapeutics Through A Multimodal Screening Approach\u0022 - Michael H. Ronzetti , University of Maryland, National Institutes of Health\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"\u0022Advancing Lyme Disease Therapeutics Through A Multimodal Screening Approach\u0022 - Michael H. Ronzetti , University of Maryland, National Institutes of Health"}],"uid":"27195","created_gmt":"2024-07-22 16:58:20","changed_gmt":"2024-07-22 17:42:08","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","field_event_time":{"event_time_start":"2024-07-26T12:00:00-04:00","event_time_end":"2024-07-26T13:00:00-04:00","event_time_end_last":"2024-07-26T13:00:00-04:00","gmt_time_start":"2024-07-26 16:00:00","gmt_time_end":"2024-07-26 17:00:00","gmt_time_end_last":"2024-07-26 17:00:00","rrule":null,"timezone":"America\/New_York"},"location":"Virtual event - see description","extras":[],"groups":[{"id":"655285","name":"GT Commercialization"},{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"},{"id":"1254","name":"Wallace H. Coulter Dept. of Biomedical Engineering"}],"categories":[],"keywords":[{"id":"187423","name":"go-bio"},{"id":"188880","name":"go-bio-commercialization"},{"id":"189814","name":"go-researchevents"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[{"id":"1795","name":"Seminar\/Lecture\/Colloquium"}],"invited_audience":[{"id":"78761","name":"Faculty\/Staff"},{"id":"174045","name":"Graduate students"},{"id":"177814","name":"Postdoc"},{"id":"78771","name":"Public"},{"id":"78751","name":"Undergraduate students"}],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003ELauren James - \u003Ca href=\u0022mailto:lauren.james@emory.edu\u0022\u003Elauren.james@emory.edu\u003C\/a\u003E\u003C\/p\u003E","format":"limited_html"}],"email":[],"slides":[],"orientation":[],"userdata":""}}}